- document
-
van der Bom, J.G. (author), de Maat, M.P.M. (author), Bots, M.L. (author), Haverkate, F. (author), de Jong, P.T.V.M. (author), Hofman, A. (author), Kluft, C. (author), Grobbee, D.E. (author), Gaubius Instituut TNO (author)An association between increased plasma fibrinogen and an increased risk for myocardial infarction (MI) is well established, but the nature of this association is subject to debate. Our aim was to shed light on the potentially causal nature of this association. We examined whether increased plasma fibrinogen, due to a condition that is...article 1998
- document
-
van der Bom, J.G. (author), de Maat, M.P.M. (author), Bots, M.L. (author), Hofman, A. (author), Kluft, C. (author), Grobbee, D.E. (author), Gaubius Instituut TNO (author)As evidence accumulates to implicate fibrinogen as a risk indicator for cardiovascular disease, it is of interest to study its seasonal variation. A population based cross-sectional study was performed among participants of the Rotterdam Study, a cohort of 7983 men and women, aged 55 years and over. Fibrinogen levels were measured by the...article 1997
- document
-
van der Bom, J.G. (author), de Knijff, P. (author), Haverkate, F. (author), Bots, M.L. (author), Meijer, P. (author), de Jong, P.T.V.M. (author), Hofman, A. (author), Kluft, C. (author), Grobbee, D.E. (author), Gaubius Instituut TNO (author)Background: Impaired fibrinolytic capacity, as assessed by euglobulin clot lysis time or plasma concentration of fibrinolytic parameters, has been associated with an increased risk of myocardial infarction (MI). We studied the association of a polymorphism in the gene for TPA and of plasma concentrations of TPA (antigen and activity) with the...article 1997
- document
-
TNO Preventie en gezondheid (author), van der Bom, J.G. (author)The term 'coronary thrombosis' was derived from clinical and pathological observations on myocardial infarction made at least 80 years ago' and perhaps even earlier.'·} It was probably not until the 1930s that clinically manifest ischaemic heart disease in the form of myocardial infarction became a familiar condition rather than the unusual...doctoral thesis 1997
- document
-
van der Bom, J.G. (author), Bots, M.L. (author), Haverkate, F. (author), Meijer, P. (author), Kluft, C. (author), Gaubius Instituut TNO (author)Objective: We studied the association of plasma concentrations of tissuetype plasminogen activator (t-PA) and the, until now single documented polymorphism of the t-PA gene, with degree of atherosclerosis and the prevalence of myocardial infarction. Design: Cross-sectional, population-based case control study. Setting: A district of Rotterdam,...article 1996
- document
-
van der Bom, J.G. (author), de Knijff, P. (author), Bots, M.L. (author), Haverkate, F. (author), Hofman, A. (author), Kluft, C. (author), Grobbee, D.E. (author), Gaubius Instituut TNO (author)Objective: Impaired fibrinolysis has been suggested to be associated with increased risk of myocardial infarction. An insertion/deletion (I/D) polymorphism of the tissue-type plasminogen activator (t-PA) gene has been described which may be associated with impaired fibrinolysis. We studied the association between this polymorphism and the...article 1996
- document
-
Bots, M.L. (author), van der Bom, J.G. (author), Haverkate, F. (author), Meijer, P. (author), Hofman, A. (author), Grobbee, D.E. (author), Kluft, C. (author), TNO Preventie en Gezondheid (author)Background and objective. A low activated protein C (APC) response increases the risk of venous thrombosis, and possibly arterial disease. Apart from the factor V Leiden mutation, other factors may determine the level of APC response. In most studies on the association with arterial disease, cardiovascular risk factors were not appropriately...article 1996
- document
-
van der Bom, J.G. (author), Bots, M.L. (author), Haverkate, F. (author), Slagboom, P.E. (author), Meijer, P. (author), Hofman, A. (author), Grobbee, D.E. (author), Kluft, C. (author), TNO Preventie en gezondheid (author)Objective: To investigate the association of activated protein C (APC) response and of the factor V Leiden mutation with myocardial infarction, stroke and transient ischémie attack. Design: Population-based case control study. Setting: A district of Rotterdam, the Netherlands. Participants: From the Rotterdam Study cohort that consists of 7983...article 1996
- document
-
van der Bom, J.G. (author), Bots, M.L. (author), Haverkate, F. (author), Slagboom, P.E. (author), Meijer, P. (author), de Jong, P.T.V.M. (author), Hofman, A. (author), Grobbee, D.E. (author), Kluft, C. (author), Gaubius Instituut TNO (author)Background: Resistance to activated protein C (APC), which results from various factors, including a mutation in the gene for coagulant factor V, has been associated with increased risk for venous thrombosis. However, its relation to arterial disease is still not well defined. Objective: To investigate the association of both response to APC and...article 1996
- document
- van der Bom, J.G. (author), Bots, M.L. (author), Haverkate, F. (author), Grobbee, D.E. (author), Kluft, C. (author), Gaubius Instituut TNO (author) article 1996
- document
-
van der Bom, J.G. (author), de Knijff, P. (author), Bots, M.L. (author), Haverkate, F. (author), Hofman, A. (author), Kluft, C. (author), Grobbee, D.E. (author), Gaubius Instituut TNO (author)Abstractconference paper 1995